Maze Therapeutics, Inc. (MAZE)
22.52
-0.92
(-3.92%)
USD |
NASDAQ |
Sep 18, 16:00
22.61
+0.09
(+0.40%)
Pre-Market: 20:00
Maze Therapeutics Total Assets (Quarterly) : 531.62M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 531.62M |
| March 31, 2026 | 419.71M |
| December 31, 2025 | 397.13M |
| September 30, 2025 | 422.06M |
| June 30, 2025 | 303.52M |
| Date | Value |
|---|---|
| March 31, 2025 | 332.84M |
| December 31, 2024 | 240.54M |
| September 30, 2024 | 192.48M |
| March 31, 2024 | |
| December 31, 2023 | 71.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 78.50M |
| Shareholders Equity (Quarterly) | 453.12M |
| Debt to Equity Ratio | 0.1333 |
| Current Ratio | 18.31 |
| Net Debt Paydown Yield | -0.42% |